T1	intervention 32 45	scalp cooling
T2	condition 68 97	chemotherapy induced alopecia
T3	eligibility 450 513	Non-metastatic breast cancer women undergoing (neo) adjuvant CT
T4	control 611 616	no SC
T5	outcome-Measure 650 741	successful hair preservation (HP) assessed clinically and by review of photographs after CT
T6	No-of-participants 778 780	51
T7	intervention-participants 813 815	34
T8	control-participants 833 835	17
T9	outcome 965 972	HP rate
T10	intervention-value 1033 1038	56.3%
T11	control-value 1042 1044	0%
T12	outcome 1061 1063	HR
T13	outcome 1105 1115	at 6 weeks
T14	intervention-value 1117 1120	89%
T15	control-value 1124 1127	12%
T16	outcome 1144 1152	12 weeks
T17	intervention-value 1154 1158	100%
T18	control-value 1162 1165	59%
T19	outcome 1180 1210	Loss of hair at PEP evaluation
T20	intervention-value 1299 1302	45%
T21	control-value 1306 1309	82%
T22	outcome 1334 1375	no grade 3-4 cold related adverse effects
